134 results
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
16 May 24
Departure of Directors or Certain Officers
4:27pm
Dermatology Division. Mr. Forth was responsible for all aspects of the commercialization of both current and future products within Neurosciences
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
and no minimum purchase requirements. Daewoong is responsible for all costs related to the manufacturing of ABP-450, including costs related to the operation … and upkeep of its manufacturing facility, and we are responsible for all costs related to obtaining and maintaining regulatory approval, including clinical
8-K
mlsj7yv0hl5o3wq 6d
17 Apr 24
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.1
syl268odv6t
17 Apr 24
Entry into a Material Definitive Agreement
4:06pm